We are solving the global challenge of antimicrobial resistance.
Viotika Life Sciences Inc. is a Canadian research company advancing novel research in pursuit of a solution to the escalating crisis of antimicrobial resistance (AMR).
Left unchecked, AMR will be responsible for up to 10,000,000 deaths a year by 2050.
It has been over 30 years since a new class of antibiotics has been successfully introduced to the market. Viotika’s VIO platform represents a new class, a new approach, and new hope.
Introducing a new paradigm for addressing AMR.
| Our Vision | A world where no one dies because of antimicrobial resistance |
|---|---|
| Our Mission | To advance our breakthrough, generational science; to develop new tools to fight bacterial infections; and to prepare these tools for market, with the support of visionary investors and partners. |